0001140361-18-024987.txt : 20180521 0001140361-18-024987.hdr.sgml : 20180521 20180521172311 ACCESSION NUMBER: 0001140361-18-024987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180517 FILED AS OF DATE: 20180521 DATE AS OF CHANGE: 20180521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAST REBECCA CENTRAL INDEX KEY: 0001456485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 18850643 MAIL ADDRESS: STREET 1: 1375 PICCARD DRIVE, SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2018-05-17 0 0000722723 HANGER, INC. HNGR 0001456485 HAST REBECCA 1375 PICCARD DRIVE SUITE 300 ROCKVILLE MD 20850 0 1 0 0 SVP, Strategic Initiatives Common Stock 2018-05-17 4 A 0 7875 0 A 50928 D Common Stock 2018-05-17 4 F 0 656 18.01 D 50272 D Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2017 and ending on December 31, 2017. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Because the Compensation Committee did not certify the attainment of the performance targets until May 17, 2018, the first tranche was not deemed vested until that date. The remainder of the performance shares will vest in equal installments on March 8, 2019, 2020 and 2021. Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Includes (i) unvested restricted shares and fully vested shares totaling 7,219 shares of stock from an initial grant of 7,875 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; (ii) unvested restricted shares and fully vested shares totaling 3,391 shares of stock from an initial grant of 4,770 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which vest on March 6, 2018 and 2019; (iii) unvested restricted shares and fully vested shares totaling 6,892 shares of stock from an initial grant of 7,500 shares of restricted stock that begins to vest on March 8, 2018; (iv) unvested restricted shares and fully vested shares totaling 4,546 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 6,112 shares of stock from an initial grant of 7,500 shares of restricted stock that begins to vest on March 7, 2017; (vi) unvested restricted shares and fully vested shares totaling 2,211 shares of stock from an initial grant of 3,180 shares of restricted stock made on March 6, 2015; (vii) fully vested shares totaling 1,635 shares of stock from an initial grant of 2,663 shares of restricted stock made on March 7, 2014; (viii) fully vested shares totaling 1,910 shares of stock from an initial grant of 3,800 shares of restricted stock and performance shares made on March 11, 2013; (ix) fully vested shares totaling 1,559 shares of stock from an initial grant of 5,200 shares of restricted stock made on March 7, 2012; [continued in next footnote] (x) fully vested shares totaling 2,181 shares of stock from an initial grant of 5,200 shares of restricted stock made on March 25, 2011; (xi) fully vested shares totaling 3,020 shares of stock from an initial grant of 7,500 shares of restricted stock made on March 30, 2010 and (xi) fully vested shares from previous awards of restricted stock to the reporting person. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Rebecca Hast 2018-05-21